| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 18.339 | 18.321 | 16.210 | 16.881 | 18.525 | 18.234 | 18.523 | 26.212 | 29.911 | 39.699 |
| Total Income - EUR | 18.346 | 18.322 | 16.280 | 17.233 | 18.525 | 18.234 | 18.523 | 26.212 | 29.911 | 39.743 |
| Total Expenses - EUR | 8.863 | 9.538 | 10.387 | 10.395 | 10.194 | 11.623 | 10.139 | 10.754 | 12.633 | 22.179 |
| Gross Profit/Loss - EUR | 9.483 | 8.783 | 5.893 | 6.838 | 8.331 | 6.611 | 8.384 | 15.459 | 17.278 | 17.564 |
| Net Profit/Loss - EUR | 8.933 | 8.417 | 5.731 | 6.669 | 8.146 | 6.429 | 8.199 | 15.197 | 16.979 | 16.372 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Medprofesa S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 575 | 940 | 1.093 | 454 | 128 | 487 | 23.467 |
| Current Assets | 30.257 | 38.137 | 35.848 | 35.888 | 38.267 | 36.903 | 39.458 | 44.304 | 52.170 | 54.527 |
| Inventories | 0 | 0 | 0 | 0 | 701 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 1.987 | 1.487 | 1.378 | 1.473 | 31.823 | 31.497 | 34.888 | 36.035 | 35.507 | 37.065 |
| Cash | 28.270 | 36.650 | 34.470 | 34.415 | 5.744 | 5.406 | 4.570 | 8.269 | 16.663 | 17.462 |
| Shareholders Funds | 29.473 | 37.590 | 35.333 | 35.823 | 38.528 | 37.132 | 39.146 | 43.503 | 51.967 | 59.526 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 784 | 548 | 515 | 640 | 679 | 864 | 766 | 928 | 690 | 21.356 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Medprofesa S.r.l.